Your fact-checks will appear here
A subtype of breast cancer that lacks estrogen, progesterone, and HER2 receptors.
shows consistent anticancer activity in cell lines and animal models—blocking pathways like PAK1, Akt/mTOR and Wnt/β‑catenin and inducing apoptosis or autophagy—but this body of evidence remains precl...
High and repeated ivermectin doses explored for oncology have been tested in humans only in limited early-phase or dose‑escalation settings, showing that higher-than-approved regimens can be tolerated...
’s interactions are driven mainly by effects on drug metabolism, transport proteins, and additive side-effect profiles, meaning it can both raise or lower levels of co‑administered drugs and magnify s...
Laboratory and animal studies show has measurable anticancer activity in breast cancer models—especially (TNBC)—and can “convert cold tumors hot,” providing a mechanistic rationale for combining it wi...